Aging into Medicare tied to higher drug costs for people with diabetes
Jul 17, 2024
Quarterly out-of-pocket costs increased by approximately $23, on average, after age 65.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Type 2 diabetes prevalence rose in the United States from 2012 to 2022
Aug 02, 2024
The prevalence was highest among non-Hispanic Black people (15.8%) and individuals aged 65 years and older (23.86%).
Most traditional cardiovascular risk factors not linked to migraine
Jul 31, 2024
Current smoking, diabetes mellitus and higher fasting glucose level all were linked to lower prevalence of migraine in women.
FDA warns of accidental overdoses from compounded versions of Ozempic
Jul 30, 2024
(HealthDay News) — People taking compounded versions of Ozempic have been overdosing on the drug, the US Food and Drug Administration warns. These ODs typically are due to miscommunications or miscalculations...
Reductions seen in HbA1c, body weight with once-weekly tirzepatide
Oct 06, 2023
Estimated mean change from baseline in HbA1c was −2.1% with tirzepatide, which met noninferiority criteria and achieved superiority.
Glycemic control superior with semaglutide 25 and 50 mg in Type 2 diabetes
Aug 04, 2023
Mean changes in HbA1c were significantly greater for semaglutide 25 mg or 50 mg versus 14 mg.
Persistent gaps exist in continuity of medication use for adults with diabetes
Jan 30, 2023
A mean of 19.5, 17.1 and 43.3% of participants did not maintain continuity of use of glucose, blood pressure or lipid medications.
Mean platelet volume linked to mortality in peritoneal dialysis patients
Nov 22, 2023
MPV ≥10.2 fL was independently associated with all-cause mortality and cardiovascular mortality.
Durable reductions in HbA1c, body weight seen with semaglutide
Oct 04, 2023
The real-world study shows greater reductions in HbA1c and body weight for patients with a proportion of days covered ≥60%.